Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by CD34 may play a role in the attachment of stem cells to the bone marrow extracellular matrix or to stromal cells. Additionally we are shipping CD34 Antibodies (995) and CD34 Proteins (31) and many more products for this protein.
Showing 10 out of 31 products:
sca-1 (show Ly6a ELISA Kits) antibody reduces both CD34+/c-kit (show KIT ELISA Kits)+ progenitor cell surge and vascular restenosis after endoluminal vascular injury in a murine model.
Aging induces loss of stemness with concomitant gain of myogenic properties of a pure population of CD34+/CD45 (show PTPRC ELISA Kits)- muscle derived stem cells.
Stem cell factor (show KITLG ELISA Kits) is essential for preserving reconstitution capacity of ex vivo expanded cord blood CD34(+) cells in Immunocompromised mice.
combinatorial expression of CD105 and CD34 receptors controls bone morphogenetic protein responsiveness in adipose-derived stem cells
Our results suggest that CD34+ cells may represent the adipose-derived mesenchymal stem cells which possess stronger multiple differentiation potential during reconstituted skin development
Data suggest that CD34 may be a specific marker for functionality, with some specificity for insulin (show INS ELISA Kits).
murine in vitro expanded bone marrow-derived murine mesenchymal stem cells can transform into CD34 expressing cells that induce sarcoma formation in vivo.
Blood-borne CD34(+) endothelial progenitor cells, characterized by active cell division and an amplified transcriptional signature, transition into resident endothelial cells during compensatory lung growth.
CD34 is necessary for efficient muscle regeneration in adult mice.
We conclude that CD34 is expressed by mucosal Dendritic Cells and plays an important role in their trafficking through the lung and to the lymph nodes.
Intramyocardial autologous CD34(+) cell administration improved exercise tolerance in patients with refractory angina.
Increased gene expression linked to the proinflammatory TGFbeta (show TGFB1 ELISA Kits) and MAPK (show MAPK1 ELISA Kits) signaling pathways were detected in CD34(+) cells of myeloproliferative neoplasm patients.
CD34 stem cell exosomes mediate ischemic tissue repair via beneficial angiogenesis. Exosome-shuttled proangiogenic miRNAs may amplify stem cell function.
miR (show MLXIP ELISA Kits)-378 regulates the angiogenic capacity of CD34(+) progenitor cells in STEMI patients.
CD34 and IL-8 (show IL8 ELISA Kits) are associated with poor prognosis of melanoma, metastasis, and neoangiogenesis
The results showed that transfection of CD34(+) cells with SiRNA targeting TGF-bRII and their co-culture with human bone marrow mesenchymal stromal cells (MSCs) could considerably increase the number of progenitors
Expression of CD34 and MMP-9 (show MMP9 ELISA Kits) accurately predicts clinical behavior detection and prognosis of GCTBs.
Expression of VEGF (show VEGFA ELISA Kits) and CD34 was critically correlated with perioperative hemorrhage in gastric cancer patients.
There was significant correlation between age and tumor size with CD34 expression in oral SCC (show CYP11A1 ELISA Kits) samples and no significant correlation between sex and tumor differentiation level. Also, there was no significant correlation between age, sex, tumor size and tumor differentiation level (grading) with CD34 expression in esophagus SCC (show CYP11A1 ELISA Kits) samples.
Normal FLT3 (show FLT3 ELISA Kits) and negative expression of CD34 and cMPL (show MPL ELISA Kits) may predict a longer overall survival in aute myeloid leukemia (show BCL11A ELISA Kits).
There is an association with CD34 immunostaining and ischemic injury of pedicle flaps.
These results suggest that CD34 may be involved in mediating the cell-to-cell adhesion between trophectoderm and the luminal epithelial cells during early pregnancy in pigs.
Combination of anti-CD34 antibody and drug-eluting stents reduces risk of coronary restenosis.
Immobilization of anti-CD34 antibody on sirolimus-eluting stents enhances endothelialization and may potentially be an effective therapeutic alternative to improve currently available drug-eluting stents.
The protein encoded by this gene may play a role in the attachment of stem cells to the bone marrow extracellular matrix or to stromal cells. This single-pass membrane protein is highly glycosylated and phosphorylated by protein kinase C. Two transcript variants encoding different isoforms have been found for this gene.
, cluster designation 34
, hematopoietic progenitor cell antigen CD34
, hematopoietic progenitor cell marker CD34